Enkephalin Therapy Improves Relapsing-Remitting Multiple Sclerosis

Multiple sclerosis (MS) is accompanied by decreases in serum endogenous enkephalin/endorphins and alterations in inflammatory cytokines. This retrospective analysis of serum levels was conducted in 53 patients with established relapsing-remitting MS treated with the disease-modifying therapies (DMT)...

Descripción completa

Detalles Bibliográficos

Autores principales:	Patel, Chirag L., Zagon, Ian S., Thomas, Gary A., McLaughlin, Patricia J.
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2020
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/70924
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!